The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 2 of the 19 sources its claims cite were checked for support.
Increased mitochondrial mass in mitochondrial myopathy mice
Open accessAbstract
We have generated an animal model for mitochondrial myopathy by disrupting the gene for mitochondrial transcription factor A ( Tfam ) in skeletal muscle of the mouse. The knockout animals developed a myopathy with ragged-red muscle fibers, accumulation of abnormally appearing mitochondria, and progressively deteriorating respiratory chain function in skeletal muscle. Enzyme histochemistry, electron micrographs, and citrate synthase activity revealed a substantial increase in mitochondrial mass in skeletal muscle of the myopathy mice. Biochemical assays demonstrated that the increased mitochondrial mass partly compensated for the reduced function of the respiratory chain by maintaining overall ATP production in skeletal muscle. The increased mitochondrial mass thus was induced by the respiratory chain deficiency and may be beneficial by improving the energy homeostasis in the affected tissue. Surprisingly, in vitro experiments to assess muscle function demonstrated that fatigue development did not occur more rapidly in myopathy mice, suggesting that overall ATP production is sufficient. However, there were lower absolute muscle forces in the myopathy mice, especially at low stimulation frequencies. This reduction in muscle force is likely caused by deficient formation of force-generating actin–myosin cross bridges and/or disregulation of Ca 2+ homeostasis. Thus, both biochemical measurements of ATP-production rate and in vitro physiological studies suggest that reduced mitochondrial ATP production might not be as critical for the pathophysiology of mitochondrial myopathy as thought previously.
Overview
CoChat Summary
TL;DR
Skeletal-muscle-specific Tfam knockout mice develop a mitochondrial myopathy with ragged-red fibers, progressive respiratory chain deficiency, and increased mitochondrial mass that partly compensates for reduced respiratory chain function. Despite lower absolute muscle forces, fatigue development is not faster, suggesting reduced mitochondrial ATP production may be less critical for pathophysiology than previously thought.
Key findings
- Myopathy mice showed progressive loss of mtDNA expression: skeletal muscle mtDNA was reduced to 31 ± 3% at 1 month, 36 ± 5% at 2 months, and 32% at 4 months; mitochondrial transcripts were reduced to 67 ± 4%, 50 ± 5%, and 30 ± 3% at the same ages; COXII protein was normal at 1 month, reduced to ≈50% at 2 months, and undetectable at 4 months.
- Mitochondrial mass increased substantially, evidenced by ragged-red fibers, electron microscopy showing enlarged accumulated mitochondria, and increased citrate synthase activity; MAPR/CS was reduced with glutamate + succinate or TMPD + ascorbate but normal with succinate + rotenone or palmitoyl-L-carnitine + malate, while MAPR/kg was less decreased than MAPR/CS, consistent with partial compensation.
- In vitro contractile studies found no faster fatigue development in myopathy mice, but lower absolute forces in EDL between 20 and 120 Hz and in soleus between 10 and 50 Hz; EDL also had shorter twitch contraction time (23.4 ± 1.2 vs 30.2 ± 1.6 ms) and half-relaxation time (20.2 ± 1.5 vs 33.0 ± 3.7 ms).
Methods
- Mice with skeletal muscle-specific disruption of Tfam were generated by mating Mlc1f-cre mice with Tfam loxP/Tfam loxP mice; myopathy mice had genotype Tfam loxP/Tfam loxP, +/Mlc1f-cre, and controls were Tfam loxP/Tfam loxP.
- Skeletal muscle was analyzed at 1, 2, and 4 months by PCR, Southern, Northern, and Western blotting, enzyme histochemistry, electron microscopy, respiratory chain enzyme assays, and mitochondrial ATP-production rate (MAPR) measurements; biochemical groups used n = 4–6 per genotype.
- Intact EDL and soleus muscles from 3–3.5-month-old control and myopathy mice (n = 5 each) were studied for force-frequency relationships, fatiguing stimulation, and recovery; statistics used two-way ANOVA for MAPR/enzyme data and unpaired t tests for other data.
Limitations
- Stated limitations: Not stated in the paper; the authors instead state that future studies are needed to investigate alternate pathophysiological mechanisms such as excessive reactive oxygen species formation and altered intracellular Ca2+ regulation.
- Evident: The model is a mouse skeletal-muscle-specific Tfam knockout, so it may not capture human mtDNA mutation disorders with heteroplasmy and variable tissue distribution.
- Evident: The mechanism of reduced muscle force is inferred rather than directly measured; the text says it is “likely caused by deficient formation of force-generating actin-myosin cross bridges and/or disregulation of Ca2+ homeostasis,” and some analyses used small groups (n = 4–6 for biochemical assays, n = 5 per genotype for contractile studies).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 1 Not valid · 10 Not checked · 44 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The apparent absence of Tfam protein at the age of 1 month demonstrates that efficient skeletal musclespecific Tfam recombination has occurred before this age and is consistent with previous reports demonstrating that the Mlc1f promoter, which regulates cre-recombinase expression in skeletal muscle, is active from embryonic day 10 (22).”
§ Increased mitochondrial mass in mitochondrial myopathy mice > Results Progressive Inhibition of mtDNA Expression in Skeletal Muscle.
What the sources say
- Partly supportedcites [22] sourceExperimental — accuracy not yet measured
The Results (p. 1467, Figs. 2–3) detect MLC1F transcripts in developing mouse muscle at 9.5 and 10.5 days post coitum, supporting early expression. The paper does not test whether the Mlc1f promoter drives Cre-recombinase or whether Tfam recombination occurred; the one-month recombination conclusion is the citing authors’ own inference. (LLM, conf=0.85)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“consistent with previous reports demonstrating that the Mlc1f promoter, which regulates cre-recombinase expression in skeletal muscle, is active from embryonic day 10 (22).”
§ Increased mitochondrial mass in mitochondrial myopathy mice > Results Progressive Inhibition of mtDNA Expression in Skeletal Muscle.
What the sources say
- Partly supportedcites [22] sourceExperimental — accuracy not yet measured
Figure 2 (p. 1467) reports detectable MLC1F transcripts in mouse myotomes at 9.5 days post coitum, and Figure 3 (p. 1468) shows them at 10.5 days. This supports early MLC1F gene expression, but the paper does not test whether an Mlc1f promoter drives Cre-recombinase expression from embryonic day 10. (LLM, conf=0.87)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Surprisingly, in vitro experiments to assess muscle function demonstrated that fatigue development did not occur more rapidly in myopathy mice, suggesting that overall ATP production is sufficient.”
- Also stated in: § Discussion · hedged
“Surprisingly, fatigue development did not occur more rapidly in Tfam knockout muscles, suggesting that decreased mitochondrial ATP production is not a critical factor.”
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The levels of mtDNA were reduced in skeletal muscle of myopathy mice in comparison with control mice at the age of 1 month (mean Ϯ SEM ϭ 31 Ϯ 3%; pairs of analyzed animals, n ϭ 6), 2 months (36 Ϯ 5%; n ϭ 7), and 4 months (32%; n ϭ 2), as demonstrated by Southern blot analyses (Fig. 1B).”
§ Increased mitochondrial mass in mitochondrial myopathy mice > Results Progressive Inhibition of mtDNA Expression in Skeletal Muscle.
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The myopathy mice displayed a highly tissue-specific knockout pattern with presence of the Tfam knockout allele (Tfam Ϫ ) only in skeletal muscle as determined by PCR analyses (Fig. 1A).”
§ Increased mitochondrial mass in mitochondrial myopathy mice > Results Progressive Inhibition of mtDNA Expression in Skeletal Muscle.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
30 more claims
Create a free account to see all 57 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 19
- Probably not a substantial claim. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Tfam KO mice do not live more than ∼20 weeks and appear healthy until 12-14 weeks, at which point a progressive clinical phenotype becomes evident (Gineste et al., 2015; Wredenberg et al., 2002).”
From Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model (2021) · cites this paper as Wredenberg et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, muscle fatigue (i.e. a drop in force during sustained or repeated contractions) remained unaffected and has been explained by an increased proportion of the muscle fiber volume being occupied by mitochondria combined with a lower energy expenditure during contractions. This reduced cost would be due to a reduced sarcoplasmic reticulum (SR) calcium (Ca2+) release resulting in a decreased”
From Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model (2021) · cites this paper as Wredenberg et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A decreased force production in fast-twitch muscle fibers of Tfam KO mice might also be masked in the present in vivo experiments by a substantial proportion of the muscle being occupied by normally contracting slow-twitch fibers in which Tfam was not knocked out (Wredenberg et al., 2002).”
From Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model (2021) · cites this paper as Wredenberg et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tfam is knocked out only in fast-twitch muscle fibers”
From Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model (2021) · cites this paper as Wredenberg et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For all the targeted cell types, TFAM depletion leads to mtDNA depletion (not reported for midbrain DA neurons), mitochondrial transcript depletion (not reported for midbrain DA neurons) and respiratory chain deficiency, suggesting that TFAM is essential for mtDNA maintenance in vivo”
From Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases (2017) · cites this paper as Wredenberg et al., 2002
Experimental — accuracy not yet measured
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Increased mitochondrial mass in mitochondrial myopathy mice > PCR, Southern Blot, Northern Blot, and Western Blot Analysis.
“Skeletal muscle samples from myopathy mice (n ϭ 5-6) and control mice (n ϭ 5-6) were collected at 1, 2, and 4 months of age.”
§ Increased mitochondrial mass in mitochondrial myopathy mice > Results Progressive Inhibition of mtDNA Expression in Skeletal Muscle.
“The levels of mtDNA were reduced in skeletal muscle of myopathy mice in comparison with control mice at the age of 1 month (mean Ϯ SEM ϭ 31 Ϯ 3%; pairs of analyzed animals, n ϭ 6), 2 months (36 Ϯ 5%; n ϭ 7), and 4 months (32%; n ϭ 2), as demonstrated by Southern blot analyses (Fig. 1B).”
Citations
Cites
Sequence and organization of the human mitochondrial genome
Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H. L., Coulson, A. R., Drouin, J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F., et al. (1981) · Nature · doi:10.1038/290457a0 · Cited by 9,636
Mitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
Adaptations of skeletal muscle to endurance exercise and their metabolic consequences
Holloszy, J. O., & Coyle, E. F. (1984) · Journal of Applied Physiology · doi:10.1152/jappl.1984.56.4.831 · Cited by 1,985
Mitochondrial transcription factor A is necessary for mtDNA maintance and embryogenesis in mice
Larsson, N.-G., Wang, J., Wilhelmsson, H., Oldfors, A., Rustin, P., Lewandoski, M., Barsh, G. S., & Clayton, D. A. (1998) · Nature Genetics · doi:10.1038/ng0398-231 · Cited by 1,594
Self-citationMuscle biopsy: A modern approach
(1975) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(75)90022-2 · Cited by 1,367
Mitochondrial Genetics: A Paradigm for Aging and Degenerative Diseases?
Wallace, D. C. (1992) · Science · doi:10.1126/science.1533953 · Cited by 1,262
Biochemical Adaptations to Endurance Exercise in Muscle
Holloszy, J. O., & Booth, F. W. (1976) · Annual Review of Physiology · doi:10.1146/annurev.ph.38.030176.001421 · Cited by 1,053
Seligman, A. M., Karnovsky, M. J., Wasserkrug, H. L., & Hanker, J. S. (1968) · The Journal of Cell Biology · doi:10.1083/jcb.38.1.1 · Cited by 883
The genetics and pathology of oxidative phosphorylation
Smeitink, J., van den Heuvel, L., & DiMauro, S. (2001) · Nature Reviews Genetics · doi:10.1038/35072063 · Cited by 724
Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA
Falkenberg, M., Gaspari, M., Rantanen, A., Trifunovic, A., Larsson, N.-G., & Gustafsson, C. M. (2002) · Nature Genetics · doi:10.1038/ng909 · Cited by 598
Self-citation
Research works printed but not linked: 3
- Ekstrand M. & Larsson, N.-G. (2002) Methods Mol. Biol.197,391-400.12013812
- Wibom R. Hagenfeldt L. & Döbeln U. v. (2002) Anal. Biochem. in press.
- Larsson N.-G., Tulinius, M. H., Holme, E., Oldfors, A., Andersen, O., Wahlström, J. & Aasly, J. (1992) Am. J. Hum. Genet.51,1201-1212.1463006
Cited by
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
“We have previously generated a series of tissue-specific Tfam knockout mouse strains with reduced mtDNA expression and severe respiratory chain deficiency in different organs, accompanied by increased cell death and/or apoptosi”
BackgroundSelf-citationSkeletal muscle fatigue: cellular mechanisms
Allen, D. G., Lamb, G. D., & Westerblad, H. (2008) · Physiological Reviews · doi:10.1152/physrev.00015.2007 · Cited by 2,495
“ploying a mouse model for mitochondrial myopathy, induced by skeletal muscle specific disruption of the gene for mitochondrial transcription factor A, showed no increase in the rate of fatigue development compared with wild-type controls, but the ability to generate force was markedly decreased in mitochondrial myopat…”
BackgroundSelf-citationMitochondrial DNA mutations in human disease
Taylor, R. W., & Turnbull, D. M. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1606 · Cited by 1,852
“The generation of mouse models that target nuclear genes involved in mtDNA maintenance or replication, such as the Tfam knockout mouse, has proved to be a more successful approac”
Chen, H., Vermulst, M., Wang, Y. E., Chomyn, A., Prolla, T. A., McCaffery, J. M., & Chan, D. C. (2010) · Cell · doi:10.1016/j.cell.2010.02.026 · Cited by 1,211
“For comparison, MLC-Cre/Tfam mice--which lack a key DNA-binding protein involved in mtDNA packaging, transcription, and replication--retain greater than 30% mtDNA levels at 4 months of age (Wredenberg et al., 2002).”
Mitochondrial transcription factor A regulates mtDNA copy number in mammals
Ekstrand, M. I. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh109 · Cited by 919
Metadata
- Authors
- Wredenberg, A., Wibom, R., Wilhelmsson, H., Graff, C., Wiener, H. H., Burden, S. J., Oldfors, A., Westerblad, H., & Larsson, N.-G.
- Affiliations
- Sahlgrenska University Hospital (SE)
- Karolinska University Hospital (SE)
- Corresponding author
- Larsson, Nils-Göran
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-11-04
- Volume
- 99
- Issue
- 23
- Pages
- 15066-15071
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC137544
- OpenAlex
- W2036351079
- Semantic Scholar
- f7ec2b12a5d6a3d9232a2cc3b388570c7e0b618e
- Cited by
- 302
- References
- 32
- Citations by year
- 2026: 5 · 2025: 16 · 2024: 15 · 2023: 11 · 2022: 16 · 2021: 14 · 2020: 19 · 2019: 11 · 2018: 10 · 2017: 12 · 2016: 17 · 2015: 15 · 2014: 13 · 2013: 15 · 2012: 14
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Stiftelsen för Strategisk Forskning
- Karolinska Institutet
- Vetenskapsrådet
- Stiftelsen Frimurare Barnhuset i Stockholm
- Stiftelsen Sven Jerrings Fond
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (NS27963, R01NS027963)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- mitochondrial myopathy, TFAM, skeletal muscle, ragged-red fibers, mitochondrial mass, respiratory chain deficiency, ATP production, muscle fatigue, muscle force, actin-myosin cross-bridges, calcium homeostasis, energy homeostasis
- MeSH terms
- Animals, Crosses, Genetic, Disease Models, Animal, DNA, Mitochondrial, DNA, Ribosomal, Electric Stimulation, Heterozygote, Mice, Inbred C57BL, Mice, Transgenic, Mitochondria, Muscle, Muscle Contraction, Muscle Relaxation, Oxygen Consumption, Reference Values, RNA, Ribosomal, 18S, Time Factors, Mitochondrial Myopathies, Mice, Knockout, Muscle Fibers, Fast-Twitch, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased mitochondrial mass in mitochondrial myopathy mice. https://app.cochat.ai/papers/10.1073/pnas.232591499
- The paper
- Wredenberg, A., Wibom, R., Wilhelmsson, H., Graff, C., Wiener, H. H., Burden, S. J., Oldfors, A., Westerblad, H., & Larsson, N.-G. (2002). Increased mitochondrial mass in mitochondrial myopathy mice. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.232591499
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.